# OnCo record paper-atlantis-lancet-respir-med-2023 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-atlantis-lancet-respir-med-2023/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-atlantis-lancet-respir-med-2023" ;
  schema:name "Combination lurbinectedin and doxorubicin versus physician's choice of chemotherapy in patients with relapsed small-cell lung cancer (ATLANTIS): a multicentre, randomised, open-label, phase 3 trial"@en ;
  schema:description "Published report from the ATLANTIS trial registered as NCT02566993, in The Lancet. Respiratory medicine (2023), chosen as the most cited paper whose own text cites the registry id."@en ;
  schema:url <https://onco.cc/key-papers/paper-atlantis-lancet-respir-med-2023/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://doi.org/10.1016/s2213-2600(22)00309-5>, <https://pubmed.ncbi.nlm.nih.gov/36252599/>, <https://europepmc.org/article/MED/36252599>, <https://clinicaltrials.gov/study/NCT02566993> ;
  onco:tag "europepmc-ingest" ;
  schema:sameAs <https://doi.org/10.1016/s2213-2600(22)00309-5> ;
  schema:datePublished "2023"^^xsd:gYear ;
  schema:author "Aix SP, Ciuleanu TE, Navarro A, et al." ;
  onco:trials <https://onco.cc/trials/atlantis/> .